MARSEILLES, FRANCE: A Phase I Study of the Anti-KIR Antibody IPH2102/BMS-986015 in Combination With Ipilimumab in Patients With Selected Advanced Solid Tumors Published on ClinicalTrials.gov
...
SOUTH SAN FRANCISCO, CA: Titan Receives $15.75 Million Up-Front Payment, up to $215 Million in Potential Milestones Plus Tiered Royalties; Titan to Host Conference Call Today at 4:05pm ET
...
TUSTIN, CA: Company Expects 20% Growth in Contract Manufacturing Revenue to Over $18 Million for Current Fiscal Year; Back-Log for Future Manufacturing Services Currently Exceeds $30 Million Covering Services to ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.